Zopiclone, sleep and health-related quality of life
β Scribed by F. Goldenberg; I. Hindmarch; C. R. B. Joyce; M. Le Gal; M. Partinen; C. Pilate
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 940 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
β¦ Synopsis
458 insomniac patients participated in a multinational, randomised, double blind, parallel groups study of zopiclone 7.5 mg versus placebo. Patients received the drug or placebo nightly for 14 days and for a further six weeks on demand. Sleep characteristics and Quality of Life measures were assessed at 14, 28 and 56 days after admission. Both groups of patients improved on these measures, but the active treatment showed significantly greater improvement compared to placebo, both after 14 days and at the end of the trial.
KEY woms-Zopiclone, insomnia, quality of life.
π SIMILAR VOLUMES
## Abstract ## Objective To assess healthβrelated quality of life (HRQOL) in abataceptβtreated children/adolescents with juvenile idiopathic arthritis (JIA). ## Methods In this phase III, doubleβblind, placeboβcontrolled trial, subjects with active polyarticular course JIA and an inadequate resp
Our purpose is to report the development and psychometric properties of a generic computer-delivered measure of health-related quality of life (HRQL) suitable for children aged 6 to 11 years, the Exeter HRQL scale (EHRQL). The theoretical model adopted is based on a definition of HRQL which assumes